Related Experiment Video
Updated: Dec 29, 2025
Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
Targeting Glutamine Addiction in Gliomas
Marta Obara-Michlewska1, Monika Szeliga1
1Department of Neurotoxicology, Mossakowski Medical Research Centre, Polish Academy of Sciences, 5 Pawińskiego Street, 02-106 Warsaw, Poland.
Abstract:
The most common malignant brain tumors are those of astrocytic origin, gliomas, with the most aggressive glioblastoma (WHO grade IV) among them. Despite efforts, medicine has not made progress in terms of the prognosis and life expectancy of glioma patients. Behind the malignant phenotype of gliomas lies multiple genetic mutations leading to reprogramming of their metabolism, which gives those highly proliferating cells an advantage over healthy ones. The so-called glutamine addiction is a metabolic adaptation that supplements oxidative glycolysis in order to secure neoplastic cells with nutrients and energy in unfavorable conditions of hypoxia. The present review aims at presenting the research and clinical attempts targeting the different metabolic pathways involved in glutamine metabolism in gliomas. A brief description of the biochemistry of glutamine transport, synthesis, and glutaminolysis, etc. will forego a detailed comparison of the therapeutic strategies undertaken to inhibit glutamine utilization by gliomas.
Insights
Gliomas, aggressive brain tumors, exhibit "glutamine addiction," a metabolic adaptation. Targeting glutamine metabolism offers a promising therapeutic strategy to combat these challenging cancers.
Area of Science:
- Neuro-oncology
- Cancer Metabolism
- Molecular Biology
Background:
- Gliomas, particularly glioblastoma (WHO grade IV), are common and aggressive brain tumors with poor patient prognosis.
- Malignant gliomas display altered metabolism, including reprogramming of nutrient pathways, to support rapid proliferation and survival.
- Glutamine addiction is a key metabolic adaptation enabling cancer cells to thrive under hypoxic conditions.
Purpose of the Study:
- To review current research and clinical efforts targeting glutamine metabolism in gliomas.
- To elucidate the biochemical pathways of glutamine transport, synthesis, and degradation in glioma cells.
- To compare therapeutic strategies aimed at inhibiting glioma glutamine utilization.
Main Methods:
- Review of existing scientific literature and clinical trial data.
- Biochemical analysis of glutamine metabolic pathways.
- Comparative analysis of therapeutic interventions targeting glutamine metabolism.
Main Results:
- Glutamine metabolism is crucial for glioma cell proliferation and survival.
- Various enzymes and transporters involved in glutamine metabolism are potential therapeutic targets.
- Inhibiting glutamine utilization presents a viable strategy for glioma treatment.
Conclusions:
- Targeting glutamine metabolism offers a novel therapeutic avenue for glioma treatment.
- Further research into glutamine pathway inhibitors is warranted for clinical application.
- Understanding glioma metabolic reprogramming is key to improving patient outcomes.
